Murdoch I, Smith AF, Baker H, Shilio B, Dhalla K. The cost and quality of life impact of glaucoma in Tanzania: An observational study. PLoS ONE 2020; 15(6): e0232796. https://doi.org/10.1371/journal.pone.0232796
Smith AF, Dhalla K, Baker H, Shilio B, Murdoch I. Determination of the cost and quality of life impact due to glaucoma in Tanzania, East Africa. Invest Ophthamol Vis Sci., 2020; 61(7):3093-3093.
Smith AF, Bourne R, Taylor HR, Jonas JB, Resnikoff S, Wormstone M. Trends in the prevalence of blindness and national income levels: findings from 157 countries from 1990 to 2015 Invest Ophthalmol. Vis. Sci., 2019; 60(9): 5465-5465.
Smith AF, Negretti G, Mascaro A, Bokre D, Baker H, Dhalla K, Murdoch IE, Glaucoma control strategies in Sub-Saharan Africa: A review of the Clinical and Health Economic Evidence, Ophthalmic Epidemiology 2018-1-17 https://doi.org/10.1080/09286586.2018.1501499
Smith AF, Negretti G, Mascaro A, Bokre D, Baker H, Dhalla K, Murdoch IE, Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence Statistical Society of Canada, 43rd Annual Scientific Meeting, Montreal, Canada, 5th June 2018.
Smith AF, Klotz A, Silva JC, Barker N. The profile of respondents to a survey of ophthalmologists in the English-speaking Caribbean: principal findings .Invest. Ophthalmol. Vis. Sci.. 2016; 57 (12), 5544-5544
Smith AF, Klotz A, Wormstone IM. Improving the drug development process by reducing the impact of adverse events: the case of cataracts considered Drug Discovery Today doi:10.1016/j.drudis.2016.01.001
Croson W, Smith AF. Conducting a consumer health solutions market research scan. Healthcare Information Management and Communications Canada – Online Supplement June 2015
Smith AF, Klotz A, Wormstone IM, Cataracts as an adverse event in the drug development process: findings from a systematic review and economic model. Invest. Ophthalmol. Vis. Sci.. 2015; 56(7): 4148
Klotz A, Harounda A, Smith AF Forecast analysis of the incidence of Tuberculosis in the Province of Quebec BMC Public Health 2013
Smith AF, Orsborn G. Estimating the annual economic burden of illness due to contact lens associated corneal infiltrative events in the United States. Eye & Contact Lens 2012 April 10
Micieli JA, Tsui E, Smith AF. Trends in Canadian Ophthalmology research. Ophthalmology. 2012 Mar;119(3):654-5.
Klotz A, Harounda A, Smith AF. Tuberculosis in Quebec: a review of trends. Journal of Public Health Research 2012 (10):33
Smith AF, Micieli JA, Micieli A. Letter to the Editor regarding our paper, An analysis of the research productivity of Canadian ophthalmology departments from 2005 to 2009 Can J Ophthalmol 2011 Oct; 46(5): 441
Micieli A, Micieli JA, Smith AF. An analysis of the research productivity of Canadian ophthalmology departments from 2005 to 2009 Can J Ophthalmol 2011 Feb; 46(1):66-71
Micieli JA, Micieli A, Smith AF. Identifying Systemic Safety Signals following Intravitreal Bevacizumab: a Systematic Review of the Literature and the Canadian Adverse Drug Reaction Database Can J Ophthalmol 2010 Jun; 45(3):231-8
Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States BMC Ophthalmology 2009; 9:13
Boureau C, Lafuma A, Jeanbat V, Smith AF, Berdeaux G. Cost of cataract surgery after implantation of three intraocular lenses. Clin Ophthalmol 2009; 3:277-85
Micieli JA, Surkont M, Smith AF. A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity. Am J Ophthalmol 2009; 148(4):536-543
Boureau C, Lafuma A, Jeanbat V, Berdeaux G, Smith AF. Incidence of Nd:YAG laser capsulototmies after cataract surgery: comparison of 3 square-edged lenses of different composition Can J Ophthalmol. 2009: 44(2):165-170
Smith AF, Waycaster C. The annual cost of bacterial conjunctivitis in the United States: Evidence from an economic modeling approach. 13th Annual ISPOR Meeting, Toronto 3-7 May 2008 Value in Health, 2008 11(3): A291
Smith AF, Lafuma A, Jeanbat V, Boureau C, Dubois V. Cost of cataract surgery after the implantation of three intraocular lenses with square edge design. Value in Health, ISPOR, Dublin 20-23 October 2007
Guest JF, Clegg JP, Smith AF. Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK. Curr Med Res Opin. 2006; 22(9):1777-85.
Clegg JP, Guest JF, Lehman A, Smith AF. The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. Ophthalmic Epidemiol 2006; 13(4):263-74.
Smith AF, Lafuma A, Berdeaux G, Berto P, Brueggenjuergen B, Magaz S, Auffarth GK, Brezin A, Caporossi A, Mendicute J. Cost-effectiveness analysis of PMMA, silicone, or acrylic intra-ocular lenses in cataract surgery in four European countries Ophthalmic Epidemiol 2005;12(5):343-51.
Smith AF, Pitt AD, Rodruiguez AE, Alio JL, Marti N, Teus M, Guillen S, Bataille L, Barnes JR. The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting. Ophthalmic Epidemiol 2005; 12(4):233-42
Pitt AD, Smith AF, Lindsell L, Voon LW, Rose PW, Bron AJ. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004; 2: 17-33
Guest JF, Greener MJ, Robinson AC, Smith AF. Impacted cerumen in primary care: composition, production, epidemiology and management Quarterly Journal of Medicine 2004; 97(8):477-88.
Auffarth G, Brezin A, Caporossi A, Lafuma A, Medicute J, Berdeaux G, Smith AF. Comparison of Nd:YAG capsulotomy rates following phacoemulsification with implantation of PMMA, Silicone or Acrylic intra-ocular lenses in four European countries. Ophthalmic Epidemiol 2004; 4: 319-29
Smith AF, Lafuma A, Berto P, Magaz S, Berdeaux G, Auffarth G, Brezin A, Caporossi A, Mendicute J, Brueggenjuergen B, Cost-Effectiveness analysis of PMMA, Silicone, and Acrylic Intra-Ocular Lenses in Cataract Therapy in Four European Countries. 6th Annual European Congress, International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain 9-11th, November, 2003 Value in Health, 2003; 6 (6): 640
Smith AF, Pitt AD, Lindsell L, Voon LW, Bron AJ, Rose PW. Economic and quality of life Impact of seasonal allergic conjunctivitis in Oxfordshire, 6th Annual European Congress, International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain 9-11th November, Value in Health, 2003; 6 (6): 636
Smith AF, Martinez C, Rubino A, Bron AJ, Pitt AD. The Burden of Allergic Conjuncitivitis in the UK: Findings from a retrospective review of the GPRD Database: 1990-2000. 6th Annual European Congress, International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain 9-11th November, 2003 Value in Health, 2003; 6 (6): 635
Smith AF, Mugford M, Vale L, Wasiak J. The cost of a Cochrane Review: A Survey of Cochrane Review Groups and Reviewers. XI Cochrane Colloquim, 31st October, 2003, Barcelona, Spain
Lafuma A, Smith AF. Cost-effectiveness of Olopatadine in seasonal allergic conjunctivitis Treatment, Expert Rev. Pharmacoeconomics Outcomes Res. 2(6) 2002: 89-94
LePen C, Smith AF, Lilliu H, Priol G. Note on a method to derive an aggregated score for assessing treatment efficacy in Seasonal Allergic Conjunctivitis, J Clinical Drug Investigation 2002; 22(11):783-789
Kesen MR, Spaeth GL, Henderer JD, Pereira ML, Smith AF, Steinmann WC. The Heidelberg Retina Tomograph vs. clinical impression in the diagnosis of glaucoma. Am-J-Ophhthalmol, 2002; 133: 613-616
Brown MM, Brown GC, Sharma S, Smith AF, Landy. A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes Int-Ophthalmol 2002; 24: 123-127
Benson WE, Regillo CD, Vander JF, Tasman W, Smith AF, Brown GC, Ho Ac, McNamara JA. Patient-initiated second medical opinions: their necessity and economic cost Retina 2001; 21: 633-638
Singh AD, Nouri M, Shields CL, Shields JA, Smith AF, Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with Hippel-Lindau disease Ophthalmology 2001; 108: 1907-1911
Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 2001; 119: 1269-1272
Shields CL, Materin MA, Shields JA, Gershenbaum E, Singh AD, Smith AF. Factors associated with elevated intraocular pressure in eyes with melanoma. Br-J-Ophthalmol 2001; 85: 666-669
Brown MM, Brown GC, Sharma S, Hollands H, Smith AF. Physician manpower and health care expenditure in the United States: a thirty-year perspective. J-Health-Care-Finance 2001; 27: 55-64
Note: For publications prior to 2001, please contact us.